ZaiQing Pharmaceuticals: Resubmitting H-share listing application on August 12, 2026.

Zejing Pharma announced that the company submitted a new application to the Hong Kong Stock Exchange on August 12, 2026, for the issuance of H shares and the listing on the main board of the Hong Kong Stock Exchange. On the same day, the application materials for this issuance and listing were published on the Hong Kong Stock Exchange's website. The application materials are in draft form and the information contained may be updated and revised in due course. The issuance and listing are still subject to the filing, approval, or authorization by relevant authorities, including the China Securities Regulatory Commission, the Hong Kong Securities and Futures Commission, and the Hong Kong Stock Exchange, and there remains uncertainty regarding this matter.